Patent · US Active

Adenosine analogs and their use

US8569259B2 · kind B2 · utility

1Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2007
Grant dateOct 29, 2013
Priority date
Expiry dateMar 7, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H21/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are adenosine analog compounds of the general formula that act as P2Y receptors, e.g., the P2Y2 receptor, including pharmaceutical compositions; and uses thereof to treat or prevent diseases associated with that receptor, e.g., disorders relating to mucus secretion, such as cystic fibrosis, chronic obstructive pulmonary disorder (COPD), asthma, constipation, chronic idiopathic constipation, dry mouth (xerostomia), gum disease, and gastrointestinal problems caused by radiation and chemotherapy for cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.